No Data
Tsubota Lab --- Publication of research paper on the results of joint research TLG-005D.
On the 19th, Tsubota Lab <4890> announced that the research results of the joint study "TLG-005D (Targeting Depression with TLG-005)" conducted with the Department of Psychiatry and Neuroscience at Keio University School of Medicine were published in the international academic journal 'Journal of Affective Disorders'. The title of the paper is 'Violet light photobiomodulation therapy for depression: A
Stable, supported by a pause in the rise of U.S. long-term Gold interest rates, etc.
[Emerging Markets Individual Stock Global Strategy] Today's emerging markets are expected to show a stable performance. Yesterday, on the 19th, the Dow Inc. rose by 71.25 points (+0.16%) to 44,627.59 dollars, continuing its upward trend. Housing starts fell short of Financial Estimates, raising concerns about economic slowdown, which weighed on stock prices. On the other hand, the minutes from the Federal Open Market Committee (FOMC) meeting held in January, published by the Federal Reserve System, indicated that they are considering slowing the balance sheet runoff until the debt ceiling issue is resolved.
＜Today's Individual Materials＞ Midac HD, Garden, Kurazushi, FIG, etc. (Announced on the 19th)
▽ Midac HD <6564.T> received a permit for changing the industrial waste disposal facility regarding the plan to increase the landfill capacity of the stable final disposal site in Hamamatsu City, Shizuoka Prefecture. ▽ Garden <274A.T> has introduced a shareholder benefit system that presents a free ticket for one bowl of family-style ramen or oil soba to shareholders holding one unit (100 shares) or more, usable at all Ichikakuya stores. ▽ Kurazushi <2695.T> has reintroduced its shareholder benefit system. ▽ FIG <4392.T> predicts consolidated operating profit for the fiscal year ending December 2025 to be between 800 million and 1.1 billion.
Key points of attention for the PTS on the 19th = Kurazushi, FIG, Welldy, ALiNK, ETC.
▽ Kura Sushi <2695.T> reintroduces the Shareholder benefit program. ▽ FIG <4392.T> forecasts consolidated operating profit for the fiscal year ending December 2025 to be between 800 million and 1.1 billion yen (2.2 to 3.0 times year-on-year). ▽ Welldy <2901.T> enters into a strategic partnership agreement with Karada Note <4014.T>. ▽ ALiNK <7077.T> introduces a preferential system for long-term Shareholding. Shareholders with more than 100 shares and a continuous holding period of over one year will receive Quo cards according to the number of Shares held. ▽ Genda
Tsubota Lab --- Recording of non-operating income (exchange gains).
On the 12th, Tsubota Lab (4890) announced that it recorded foreign exchange gains as operating income for the cumulative period of the third quarter of fiscal year ending March 2025 (April 1, 2024 - December 31, 2024). The company had recorded a foreign exchange loss of 0.005 billion yen during the interim accounting period of fiscal year ending March 2025 (April 1, 2024 - September 30, 2024). However, due to subsequent volatility in the exchange rate, during the third quarter accounting period (October 1, 2024 - December 31, 2024).
Tsubota Lab --- Significant profit increase and return to profitability in Q3, a licensing agreement reached with an overseas pharmaceutical company regarding non-clinical trial data and some clinical trial results.
On the 12th, Tsubota Lab <4890> announced its third-quarter financial results for the fiscal year ending March 2025 (April to December 2024). Revenue increased by 355.2% year-on-year to 0.792 billion yen, operating profit was 0.09 billion yen (compared to a loss of 0.956 billion yen in the same period last year), ordinary profit was 0.122 billion yen (compared to a loss of 0.95 billion yen in the same period last year), and quarterly net profit was 0.084 billion yen (compared to a loss of 0.955 billion yen in the same period last year). In research and development, efforts continue for the discovery of new intellectual property and the addition of new pipelines through collaborative research with partner institutions.